eLaws | eCases | United States Code | Federal Courts |
Home » 2013 Issues » 78 FR (11/26/2013) » 2013-28447. In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading

  2013-28447. In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading  

  • Start Preamble Start Printed Page 70617 November 22, 2013.

    It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Pure H20 Bio-Technologies, Inc. because questions have arisen as to its operating status, if any.

    The Commission is of the opinion that the public interest and the protection of the investors require a suspension of trading in the securities of the above-listed company.

    Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EST on November 22, 2013, through 11:59 p.m. EST on December 6, 2013.

    Start Signature

    By the Commission.

    Jill M. Peterson,

    Assistant Secretary,

    End Signature End Preamble

    [FR Doc. 2013-28447 Filed 11-22-13; 11:15 am]

    BILLING CODE 8011-01-P

Visit the Official Version
Leave a Comment

Document Information

Published:
11/26/2013
Department:
Securities and Exchange Commission
Entry Type:
Notice
Document Number:
2013-28447
Pages:
70617-70617 (1 pages)
Docket Numbers:
File No. 500-1
EOCitation:
of 2013-11-22
PDF File:
2013-28447.pdf